Juventas Therapeutics juventasinc.com


Juventas Therapeutics, formerly AcelleRx Therapeutics, Juventas Therapeutics is a privately held, clinical stage biotechnology company focused on developing non-viral gene therapies to treat advanced cardiovascular diseases. The Company's lead product candidate, JVS-100, is a non-viral gene therapy undergoing evaluation in clinical studies for the treatment of advanced cardiovascular diseases.

Juventas Therapeutics, formerly AcelleRx Therapeutics, Juventas Therapeutics is a privately held, clinical stage biotechnology company focused on developing non-viral gene therapies to treat advanced cardiovascular diseases. The Company's lead produc...Show all

Company (Alive / Active)

Phone: 216-445-0830

Fax:

3615 Superior Avenue
Suite 4403C
Cleveland, 44114
Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Juventas Therapeutics $42.2M May 12, 2015
ImaRx Therapeutics $21.7M Dec 9, 2005
AcelleRX Therapeutics $0M Dec 13, 2016
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Juventas Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 19 investors

Competitors

Company Status Description Investors
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Sdf-1 delivery for treating ischemic tissue Jun 07, 2013 Nov 11, 2014 Patent
Use of sdf-1 to mitigate scar formation Oct 12, 2012 Mar 25, 2014 Patent
Sdf-1 delivery for treating ischemic tissue Jul 24, 2012 Aug 20, 2013 Patent
Sdf-1 delivery for treating ischemic tissue Jul 24, 2012 Aug 20, 2013 Patent
The use of sdf-1 to mitigate scar formation Mar 15, 2014 Application
See all 8 patents